Towa Pharmaceutical Co., Ltd. (TWAPF)
25.98
0.00 (0.00%)
USD |
OTCM |
Aug 25, 16:00
Towa Pharmaceutical Shareholders Equity (Quarterly) : 1.123B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.123B |
| March 31, 2026 | 1.120B |
| December 31, 2025 | 1.210B |
| September 30, 2025 | 1.218B |
| June 30, 2025 | 1.196B |
| March 31, 2025 | 1.148B |
| December 31, 2024 | 1.075B |
| September 30, 2024 | 1.112B |
| June 30, 2024 | 1.013B |
| March 31, 2024 | 1.030B |
| December 31, 2023 | 1.056B |
| September 30, 2023 | 984.16M |
| June 30, 2023 | 996.28M |
| March 31, 2023 | 1.029B |
| December 31, 2022 | 1.044B |
| September 30, 2022 | 958.49M |
| June 30, 2022 | 1.008B |
| March 31, 2022 | 1.089B |
| December 31, 2021 | 1.135B |
| September 30, 2021 | 1.133B |
| June 30, 2021 | 1.100B |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 1.082B |
| September 30, 2020 | 1.033B |
| June 30, 2020 | 982.05M |
| Date | Value |
|---|---|
| March 31, 2020 | 969.52M |
| December 31, 2019 | 926.96M |
| September 30, 2019 | 905.51M |
| June 30, 2019 | 877.74M |
| March 31, 2019 | 829.12M |
| December 31, 2018 | 808.98M |
| September 30, 2018 | 750.95M |
| June 30, 2018 | 746.40M |
| March 31, 2018 | 751.48M |
| December 31, 2017 | 717.13M |
| September 30, 2017 | 697.21M |
| June 30, 2017 | 677.98M |
| March 31, 2017 | 672.57M |
| December 31, 2016 | 635.14M |
| September 30, 2016 | 691.80M |
| June 30, 2016 | 670.79M |
| March 31, 2016 | 628.19M |
| December 31, 2015 | 578.66M |
| September 30, 2015 | 568.71M |
| June 30, 2015 | 583.09M |
| March 31, 2015 | 584.10M |
| December 31, 2014 | 565.85M |
| September 30, 2014 | 579.90M |
| June 30, 2014 | 600.22M |
| March 31, 2014 | 584.04M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 46.50B |
| Daiichi Sankyo Co., Ltd. | 10.48B |
| Eisai Co., Ltd. | 5.578B |
| Chugai Pharmaceutical Co., Ltd. | 12.48B |
| Santen Pharmaceutical Co., Ltd. | 1.847B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.958B |
| Total Liabilities (Quarterly) | 1.835B |
| Debt to Equity Ratio | 1.26 |
| Current Ratio | 2.821 |
| Net Debt Paydown Yield | 2.08% |